Journals / İzmir Dr. Behçet Uz Çocuk Hastanesi Dergisi / 2019 / Cilt: 9 - Sayı: 3

Evaluation of 17 Patients with Transverse Myelitis in Terms of Clinical, Treatment and Prognosis

Çocukluk Çağı Transvers Miyelitli 17 Olgunun Klinik, Tedavi ve Prognoz Açısından Değerlendirilmesi

Pages
229–234
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There is a need for extensive research to determine prognostic factors.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: In this study, it was aimed to identify the clinical findings, treatment modalities and factors affecting the prognosis of patients who were followed up and treated with the diagnosis of transverse myelitis.
📊
Key Findings & Data:Methods: A total of 17 patients diagnosed and treated with the diagnosis of acute transverse myelitis between 2006 and 2016 were evaluated in Child Health and Diseases Services.
💡
Conclusion & Impact:There is a need for extensive research to determine prognostic factors.
🔬Design:Research Article
📍Scope:2006 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: In this study, it was aimed to identify the clinical findings, treatment modalities and factors affecting the prognosis of patients who were followed up and treated with the diagnosis of transverse myelitis. Methods: A total of 17 patients diagnosed and treated with the diagnosis of acute transverse myelitis between 2006 and 2016 were evaluated in Child Health and Diseases Services. Results: Nine (52.9%) patients were boys, 8 (47.1%) were girls and the mean age was 9.24±4.16 years. The complaints of the cases observed at admission were weakness in16 (94.1%) and numbness in the feet in 1 (5.9%) patient Twelve (70.6%) patients had a history of infection. Upper respiratory tract infections and gastrointestinal system infections were found in 7 (58.3%) and 5 (41.7%) cases,respectively. Gender, history of infection, type of infection, cranial nerve involvement, presence of autonomic symptoms, and treatment modality were not effective factors on prognosis. The duration of hospitalisation in intensive care unit (ICU) was 4.47±6.79 days and the total length of hospital stay was 17.59±12.01 days. It was seen that the need for respiratory support increased the total length of stay in intensive care unit and hospital. Conclusion: Prognosis is generally good in childhood with acute transverse myelitis cases. We have not found an effective factor on prognosis in our study. There is a need for extensive research to determine prognostic factors.

Özet

Amaç: Bu çalışmada, akut transvers miyelit tanısıyla takip ve tedavi edilen hastaların klinik bulgularının, tedavi şekillerinin ve prognozu etkileyen faktörlerin tanımlanması amaçlanmıştır. Gereç: Çocuk Sağlığı ve Hastalıkları servislerinde 2006-2016 yılları arasında akut transvers miyelit tanısıyla takip ve tedavi edilen toplam 17 hasta değerlendirildi. Bulgular: Hastaların 9’u (%52,9) erkek, 8’i (%47,1) kız ve yaş ortalamaları 9,24±4,16 yıl idi. Olguların başvuruda gözlenen yakınmaları; 16 (%94,1) hastada güçsüzlük ve 1 hastada (%5,9) ayaklarda uyuşma idi. On yedi hastanın, 12’sinde (%70,6) geçirilmiş enfeksiyon öyküsü mevcuttu. Bunların 7’si (%58,3) üst solunum yolu enfeksiyonu (ÜSYE) ve 5’i (%41,7) gastrointestinal sistem enfeksiyonu idi. Cinsiyet, geçirilmiş enfeksiyon öyküsü, enfeksiyon tipi, kranial sinir tutulumu, otonom semptom varlığı ve tedavi şekli prognozda etkisiz faktörlerdi. Hastalarının yoğun bakımda kalış süresi 4,47±6,79 gün, hastanede toplam kalış süresi 17,59±12,01 gün idi. Solunum desteği gereksiniminin, yoğun bakımda ve hastanede toplam kalış süresini arttırdığı görüldü. Sonuç: Prognoz, çocukluk çağı ATM olgularında genelde iyidir. Çalışmamızda, prognoz üzerine etkili bir faktör saptamadık. Prognostik faktörlerin belirlenmesine yönelik geniş araştırmalara gereksinim vardır.

🔖

Cite This Article

İNCECİK, F., TURAN, M., HERGÜNER, M. Ö., ALTUNBAŞAK, Ş., YILDIZTAŞ, D. (2019). Evaluation of 17 Patients with Transverse Myelitis in Terms of Clinical, Treatment and Prognosis. İzmir Dr. Behçet Uz Çocuk Hastanesi Dergisi, Cilt: 9 - Sayı: 3, 229–234. https://ajindex.com/articles/268680

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Defresne P, Meyer L, Tardieu M, Scalais E, Nuttin C, De Bont B, et al. Efficacy of high dose steroid therapy in children with severe acute transverse myelitis. J Neurol Neurosurg Psychiatry. 2001;1:272-4.
  2. Awad A, Stüve O. Idiopathic transverse myelitis and neuromyelitis optica: clinical profiles, pathophysiology and therapeutic choices. Curr Neuropharmacol. 2011;9:417-28.
  3. Proposed diagnostic criteria and nosology of acute transverse myelitis. Transverse Myelitis Consortium Working Group. Neurology. 2002;59:499-505.
  4. Thomas T, Branson HM, Verhey LH, Shroff M, Stephens D, Magalhaes S, et al. The demographic, clinical, and magnetic resonance imaging (MRI) features of transverse myelitis in children. J Child Neurol. 2012;27:11-21.
  5. Suthar R, Sankhyan N, Sahu JK, Khandelwal NK, Singhi S, Singhi P. Acute transverse myelitis in childhood: A single centre experience from North India. Eur J Paediatr Neurol. 2016;20:352-60.
  6. Gökben S. Transvers Miyelit. Güncel Pediatri Dergisi. 2008;6:107-8
  7. Paine RS, Byers RK. Transverse myelopathy in childhood. AMA Am J Dis Child. 1953;85:151.
  8. Pidcock FS, Krishnan C, Crawford TO, Salorio CF, Trovato M, Kerr DA. Acute transverse myelitis in childhood: centerbased analysis of 47 cases. Neurology. 2007;68:1474-80.
  9. Canpolat M, Gümüş H, Per H, Poyrazoğlu HG, Yıkılmaz A, Çoşkun A, et al. Çocukluk çağı akut transvers myelit olgularında uzun süreli izlem, tedavi ve prognoz. J Clin Anal Med. 2014;5:294-9
  10. Defresne P, Hollenberg H, Husson B, Tabarki B, Landrieu P, Huault G, et al. Acute transverse myelitis in children: clinical course and prognostic factors. J Child Neurol. 2003;18:401-6.
  11. Berman M, Feldman S, Alter M, Zilber N, Kahana E. Acute transverse myelitis: incidence and etiologic considerations. Neurology. 1981;31:966.
  12. Scott TF, Frohman EM, De Seze J, Gronseth GS, Weinshenker BG. Evidence-based guideline: clinical evaluation and treatment of transverse myelitis: report of the therapeutics and Technology assessment Subcommittee of the American Academy of neurology. Neurology. 2011;77:2128-34. https://doi.org/10.1212/W